1. Incorporation of [14C]leucine into protein in rat liver slices, incubated in vitro, increased as the concentration of unlabelled amino acids in the incubation medium was raised. A plateau of incorporation was reached when the amino acid concentration was 6 times that present in rat plasma. Labelling ofRNA by [3H]orotic acid was not stimulated by increased amino acid concentration in the incubation medium. 2. When amino acids were absent from the medium, or present at the normal plasma concentrations, no effect of added growth hormone on labelling of protein or RNA by precursor was observed. 3. When amino acids were present in the medium at 6 times the normal plasma concentrations addition of growth hormone stimulated incorporation of the appropriate labelled precursor into protein of liver slices from normal rats by 31%, and into RNA by 22%. A significant effect was seen at a hormone concentration as low as IOng/ml. 4. Under the same conditions addition of growth hormone also stimulated protein labelling in liver slices from hypophysectomized rats. Tissue from hypophysectomized rats previously treated with growth hormone did not respond to growth hormone in vitro. 5. No effect of the hormone on the rate or extent of uptake of radioactive precursors into acid-soluble pools was found. 6. Cycloheximide completely abolished the hormone-induced increment in labelling of both RNA and protein. 7. It was concluded that, in the presence of an abundant amino acid supply, growth hormone can stimulate the synthesis of protein in rat liver slices by a mechanism that is more sensitive to cycloheximide than is the basal protein synthesis. The stimulation of RNA labelling observed in the presence of growth hormone may be a secondary consequence of the hormonal effect on protein synthesis. 8. The mechanism of action of growth hormone on liver protein synthesis in vitro was concluded to be similar to its mechanism of action in vivo.
. Growth hormone stimulates amino acid incorporation into protein when added to the medium in which diaphragm muscle is incubated Manchester & Young, 1959) or with which liver is perfused (Jefferson & Korner, 1967) but it has never been shown to be effective on protein or RNA synthesis when added to cell-free systems. Jackson & Sells (1967) were unable to obtain an effect of growth hormone, added in vitro, on RNA formation in rat liver slices. There is evidence for an amino acid requirement for stimulation of protein-labelling by growth hormone in perfused liver (Jefferson & Korner, 1967) . We therefore investigated the effects of growth hormone on RNA and protein metabolism in liver slices from intact and hypophysectomized rats in the presence of various concentrations of amino acids in the incubation medium. The readily defined conditions of this system have also permitted experiments designed to test the effect of growth hormone on RNA synthesis in relation to its effect on protein synthesis. A preliminary account of some of these findings has been published (Clemens & Korner, 1969 (Umbreit, Burris & Stauffer, 1964) which was gassed before use with 02+CO2 (95:5). Care was taken to avoid damaging the liver lobes during handling. The livers were rinsed once to remove blood and then rapidly sliced to a thickness of 0.5mm with a StadieRiggs tissue slicer (Stadie & Riggs, 1944) which was maintained at 0-40C throughout. The first and last slices were discarded. The liver slices were rinsed three times in ice-cold Krebs-Ringer buffer, drained, and four slices were placed in the incubation medium in each conical flask, with approx. lml of medium/lOOmg wet wt. of tissue. Equal amounts of tissue were present in all incubation flasks. The incubation medium was KrebsRinger bicarbonate buffer containing 3% (w/v) bovine albumin powder (fraction V from bovine plasma; Armour Pharmaceutical Co. Ltd., Eastbourne, Sussex, U.K.), 8mM-glucose and a mixture of 20 L-amino acids in multiples of the concentrations found in rat serum, which were (in ,umol/100ml): arginine, 22; asparagine, 3.8; aspartic acid, 3.8; threonine, 29; serine, 29; glutamic acid, 19; glycine, 43; alanine, 48; valine, 20; methionine, 7; isoleucine, 9; leucine, 17; tyrosine, 9; phenylalanine, 8; histidine, 9; lysine, 48; proline, 24; cysteine, 3.8; glutamine, 19; tryptophan, 6.9 (Scharff & Wool, 1964; Schimassek & Gerok, 1965) . The labelled leucine or orotic acid was added as described in the legend of each figure and table. The incubation was carried out at 37°C in a shaking water-bath under 02+CO2 (95:5). At the end of incubation samples of the medium were taken for determination of radioactivity and each slice in which radioactivity incorporation into protein or RNA was to be measured was rapidly chilled in ice-cold 0.9% NaCl and separately homogenized in the same solution (approx. lml/lOOmg of tissue). Slices in which acid-soluble radioactivity was to be measured were blotted, weighed on a torsion balance and homogenized in 1 ml of 5% (w/v) trichloroacetic acid.
Determination of radioactivity incorporated into protein.
The homogenized slices were treated with 5ml of 0.5M-HC104 aad the procedure of Munro, Jackson & Korner (1964) was used to free the resulting precipitate of amino acids, RNA and lipid, and to measure the radioactivity in the sample. The radioactivity of samples was counted in a Nuclear-Chicago gas-flow counter and corrections were made for background counts and self-absorption. Results are reported as c.p.m. incorporated/mg of protein.
The counting efficiency was approx. 18%.
Determinations of radioactivity incorporated into RNA. The homogenized slices were treated with ice-cold 20% (w/v) trichloroacetic acid and RNA was extracted, determined and its radioactivity determined as described by Jefferson & Korner (1967) in a Beckman model LS 100 scintillation counter, with an aqueous scintillation solution as described by Turner (1968) . All samples were equally quenched. Results are reported as c.p.m. incorporated/mg of RNA. The counting efficiency was approx. 31%.
Determination of radioactivity in the acid-soluble pool. The tissue homogenates in trichloroacetic acid were centrifuged for 10min at 400g in an MSE Mistral 4L centrifuge and the radioactivities of 0.25ml samples of the supernatants were counted in 3ml of aqueous scintillation fluid in a Packard Tri-Carb scintillation counter. Counting efficiency was determined by the channels-ratio method and was approximately 85% for 14C and 20% for 3H. Results are expressed as c.p.m./mg wet wt. of tissue.
Determination of radioactivity in the incubation medium. Samples (0.2ml) of the medium were taken at the end of the incubation and their radioactivities counted in 3ml of aqueous scintillation fluid. Counting efficiency was determined by the channels-ratio or external-standardratio methods and results are expressed as nmol of labelled precursor/ml of incubation medium. Korner, unpublished work) . Table 1 shows the results of several incubations in which growth hormone was added to the medium at a concentration of 1 l,g/ml, with various concentrations of amino acids present. There is no significant effect of the hormone on labelling of protein or RNA when amino acids are absent or when they are present at normal plasma concentrations. When the concentration of amino acids is 6 times that present in normal rat plasma, growth hormone stimulates the incorporation of [14CCleucine into protein by 31% and incorporation of [3H]orotic acid into RNA by 22%. Table 2 shows the effect of various concentrations of growth hormone on labelling of protein in liver slices incubated with 6 times the normal plasma concentration of amino acids. Significant effects of the hormone were obtained at a concentration of lOng/ml, which is well within the physiological range (Schalch & Reichlin, 1966 X. 5
x-~g rowth hormone did not stimulate incorporation to a greater extent.
Liver slices from hypophysectomized rats also responded to growth hormone in vitro in terms of increased incorporation of amino acids into protein (Table 3) . Injection of growth hormone into hypophysectomized rats 1 h before death had a similar stimulatory effect, but when the hormone was also added in vitro to tissue from these animals it did not significantly stimulate any further protein labelling.
The observed increases in incorporation into protein and RNA in the presence of growth hormone could be caused by an increased rate of synthesis of these macromolecules or by increases in the specific radioactivities of the pools of precursors from which they are synthesized, or both.
We have measured the rate of uptake of leucine and orotic acid into the acid-soluble fraction of rat liver slices under the same conditions of incubation that permitted a growth-hormone-induced stimulation of incorporation. There was no effect of the (Talwar et al. 1962; Korner, 1960) , when it is added to the medium in which diaphragm muscle is incubated Fig. 2 . Uptake of [14C]leucine into the acid-soluble (Manchester & Young, 1959; fraction of incubated liver slices from normal rats. At the 1959) or when it is added to the medium perfusing start of incubation, the medium contained 8mM-glucose, rat liver (Jefferson & Korner, 1967 Fig. 2 . The results for orotic results from experiments involving incorporation acid uptake are shown in Fig. 3 . of radioactive precursors into macromolecules in These results suggest that the observed increases whole cells. The observed rates of incorporation in incorporation of [14C]leucine into protein and reflect not only rates of synthesis of RNA and [3H]orotic acid into RNA reflect increases in rates protein, but also the specific radioactivities of the of synthesis of the macromolecules. These increases functional precursor pools from which these molecould occur independently of one another or one cules are derived. Growth hormone can stimulate could be secondary to the other. To test these the accumulation of the non-metabolizable amino alternatives, slices were incubated with [3H]orotic acid, aminoisobutyrate, into diaphragm (Kostyo, acid and at high amino acid concentrations in the Hotchkiss & Knobil, 1959) and into several tissues presence of cycloheximide. Table 4 presents results in the hypophysectomized rat, including liver showing that 25,ug of cycloheximide/ml, which (Riggs & Walker, 1960) . Kostyo (1964) and inhibits protein synthesis by 88% (Fig. 4) , did not Knobil (1966) , however, have shown that growthinhibit the labelling of RNA in control slices in 1 h hormone stimulation of incorporation of amino of incubation. It did, however, abolish the growth-acids into diaphragm protein can occur in circum- 100+6 (15) 116+9 (13) 127±7 (15) 105±8 ( stances where no effect on intracellular concentration of label is detectable. Our own results (Figs. 2 and 3) show no effect of the hormone on rate of precursor uptake into the acid-soluble fraction of liver slices, and suggest that the effects on protein and RNA labelling are not caused solely by changes in the specific radioactivities of precursor pools. However, the possible existence of intracellular compartmentation means that sizes and specific radioactivities of acid-soluble pools, as measured, may not be the same as those of the functional pools within cells. Indeed, Hider, Fern & London (1969) have presented evidence in favour of direct incorporation of amino acids into protein from the extracellular pool in the extensor digitorum longus muscle of rats, and Guidotti, Ragnotti & Rossi (1964) (Jefferson & Korner, 1967) and is confirmed by the present experiments. We have also shown a similar requirement for a stimulation of RNA labelling by growth hormone. This need could explain the lack of effect of growth hormone on RNA synthesis in liver slices reported by Jackson & Sells (1967) , who did not have amino acids in their incubation medium. The concentrations of amino acids in the liver, after incubation in medium containing them in concentrations 6 times those in the plasma, are all raised above the values for unincubated tissue (M. J. Clemens, unpublished work).
The effect of amino acids in permitting a stimulation of protein labelling by growth hormone may be directly due to a low intracellular concentration of one of them causing it to become rate-limiting during the incubation, unless it is present in abundance. The explanation might be more complex than this, however, since the necessity for amino acids may be connected with the mechanism of action of the hormone. It is known that the ability of liver ribosomes to synthesize protein can be stimulated by growth hormone in vivo (Korner, 1968) and amino acids in vivo and in vitro (Wunner, Bell & Munro, 1966; Staehelin, Verney & Sidransky, 1967; Jefferson & Korner, 1969; Hanking & Roberts, 1965; Baliga, Pronczuk & Munro, 1968 ; M. J. Clemens, V. M. Pain & A. Korner, unpublished work) . Thus growth hormone may stimulate ribosomal activity by increasing the availability of amino acids to the protein-synthesizing machinery of the cell.
Liver slices from hypophysectomized rats Elso respond to growth hormone in vitro, but if the hormone has already been administered 1 h before death the tissue becomes refractory to any further stimulation in vitro. This suggests that growthhormone stimulates protein synthesis in liver in vitro by a similar mechanism to its action in the whole animal. It is, of course, possible that some growth hormone remains associated with the liver when the latter is removed from an animal recently injected with the hormone, and that maximal stimulatory effects on liver protein synthesis continue to be exerted in vitro just as if the hormone had been added to the incubation medium.
The results of incubations with cycloheximide reported here (Table 4) suggest that the observed stimulation of RNA labelling by growth hormone is secondary to an effect on protein synthesis. The amino acid requirement for a growth-hormone stimulation of RNA labelling also implicates a mechanism involving protein synthesis. Further, the results in Fig. 4 indicate that the growthhormone-induced increment in labelling of protein is more sensitive to inhibition by low doses of cycloheximide than is basal protein synthesis. Evidence that growth hormone acts at the level of translation rather than transcription is provided by studies on the effects of the hormone on protein synthesis in the absence of RNA synthesis (Korner, 1964; Martin & Young, 1965) . Rizzo & Webb (1969) have shown that factors that affect the rate of translation of mRNA and polyribosome size in liver also bring about changes in the rate of ribosome synthesis. Since growth hormone is known to stimulate formation of polyribosomal aggregates, at the expense of free monoribosomes (Korner, 1964; Staehelin, 1965) , such an effect could lead to an increased rate of ribosomalprecursor-RNA synthesis, as a consequence of the increased rate of protein synthesis.
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